• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.04% Nasdaq Up 1.44%

    Celgene Corporation (CELG)

    -NasdaqGS
    118.00 Up 2.54(2.20%) 3:21PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:115.46
    Open:117.68
    Bid:118.22 x 200
    Ask:118.27 x 100
    1y Target Est:151.78
    Beta:2.0724
    Earnings Date:Oct 21 - Oct 26 (Est.)
    Day's Range:115.71 - 118.54
    52wk Range:83.16 - 140.72
    Volume:3,622,406
    Avg Vol (3m):4,859,100
    Market Cap:93.29B
    P/E (ttm):44.68
    EPS (ttm):2.64
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Comparison

    Symbol% ChgMkt Cap
    CELGUp 2.20%93.29B
    JNJUp 0.60%256.53B

    Key Statistics

    Forward P/E (1 yr):19.87
    P/S (ttm):10.83
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :4.78
    Quarterly EPS Est (Sep-15) :1.21
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):0.97

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases in the United States and Internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback